89 related articles for article (PubMed ID: 2700160)
21. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort.
Vogel M; Voigt E; Schäfer N; Goldmann G; Schwarz N; Kalff JC; Sauerbruch T; Wolff M; Rockstroh JK; Spengler U
Liver Transpl; 2005 Dec; 11(12):1515-21. PubMed ID: 16315295
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of hepatitis C virus infection after liver transplantation.
Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
[TBL] [Abstract][Full Text] [Related]
23. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
[TBL] [Abstract][Full Text] [Related]
24. Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.
Demetris AJ; Jaffe R; Sheahan DG; Burnham J; Spero J; Iwatsuki S; Van Theil DH; Starzl TE
Am J Pathol; 1986 Oct; 125(1):161-72. PubMed ID: 3535528
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
26. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
[TBL] [Abstract][Full Text] [Related]
27. Auxiliary liver transplantation for fulminant hepatitis B: results from a series of six patients with special emphasis on regeneration and recurrence of hepatitis B.
Durand F; Belghiti J; Handra-Luca A; Francoz C; Sauvanet A; Marcellin P; Farges O; Bernuau J; Valla D
Liver Transpl; 2002 Aug; 8(8):701-7. PubMed ID: 12149763
[TBL] [Abstract][Full Text] [Related]
28. Renal transplant in hepatitis B and C positive patients--a ten years experience.
Rathod JR; Sirsat RA; Shah BV
J Assoc Physicians India; 2002 Jun; 50():766-70. PubMed ID: 12240839
[TBL] [Abstract][Full Text] [Related]
29. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
30. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of auxiliary partial living donor liver transplantation for fulminant hepatic failure as an aid for small-for-size graft: single center experience.
Kobayashi T; Sato Y; Yamamoto S; Oya H; Hara Y; Watanabe T; Kokai H; Hatakeyama K
Transplant Proc; 2009; 41(1):262-4. PubMed ID: 19249530
[TBL] [Abstract][Full Text] [Related]
32. [Orthotopic liver transplantation: report of 70 cases].
Chen G; He X; Zhu X
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):679-83. PubMed ID: 11769601
[TBL] [Abstract][Full Text] [Related]
33. Endovascular stent placement for interposed middle hepatic vein graft occlusion after living-donor liver transplantation using right-lobe graft.
Shin JH; Sung KB; Yoon HK; Ko GY; Kim KW; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Song HY; Ha TY
Liver Transpl; 2006 Feb; 12(2):269-76. PubMed ID: 16447197
[TBL] [Abstract][Full Text] [Related]
34. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine.
Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U
Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191
[TBL] [Abstract][Full Text] [Related]
35. Histological and clinical outcome after liver transplantation for hepatitis C.
Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation.
Pfau PR; Kochman ML; Lewis JD; Long WB; Lucey MR; Olthoff K; Shaked A; Ginsberg GG
Gastrointest Endosc; 2000 Jul; 52(1):55-63. PubMed ID: 10882963
[TBL] [Abstract][Full Text] [Related]
37. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
[TBL] [Abstract][Full Text] [Related]
38. Lamivudine treatment for acute severe hepatitis B: a pilot study.
Schmilovitz-Weiss H; Ben-Ari Z; Sikuler E; Zuckerman E; Sbeit W; Ackerman Z; Safadi R; Lurie Y; Rosner G; Tur-Kaspa R; Reshef R
Liver Int; 2004 Dec; 24(6):547-51. PubMed ID: 15566503
[TBL] [Abstract][Full Text] [Related]
39. Live donor liver transplantation for fulminant hepatic failure in children.
Liu CL; Fan ST; Lo CM; Tam PK; Saing H; Wei WI; Yong BH; Tsoi NS; Wong J
Liver Transpl; 2003 Nov; 9(11):1185-90. PubMed ID: 14586880
[TBL] [Abstract][Full Text] [Related]
40. Posttransplantation chronic hepatitis in fulminant hepatic failure.
Mohamed R; Hubscher SG; Mirza DF; Gunson BK; Mutimer DJ
Hepatology; 1997 Apr; 25(4):1003-7. PubMed ID: 9096611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
